CorMedix announces new commercial agreement (NASDAQ:CRMD)09/10/2024 CorMedix (NASDAQ:CRMD) on Monday stated it has entered right into a multi-year commercial provide contract with a worldwide healthcare firm for the availability of DefenCath to…
